| Patents for C07D - Heterocyclic compounds (10,420) |
|---|
| 06/13/2001 | CN1299365A Hygromycin A derivatives |
| 06/13/2001 | CN1299361A Hypnotic beta-carboline derivatives, process for their prepn. and their use as medicinal products |
| 06/13/2001 | CN1067075C Pyrrolo-gyrrolone used as neutrophil elastase inhibitor |
| 06/13/2001 | CN1067071C Carboline derivatives |
| 06/13/2001 | CN1067053C Process for preparing intermediate of derivatives of monocyclic beta-lactam antibiotics |
| 06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
| 06/12/2001 | US6245786 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 06/12/2001 | US6245760 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/07/2001 | WO2001040190A1 4-carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as cetp inhibitor |
| 06/07/2001 | WO2001040189A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 06/07/2001 | CA2392979A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline crystal |
| 06/07/2001 | CA2392504A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 06/06/2001 | EP1104403A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 06/06/2001 | CN1066733C 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
| 06/06/2001 | CN1066720C Process for producing pharmaceutically active CNS compounds |
| 06/06/2001 | CN1066719C Process for producing pharmaceutically active CNS compounds |
| 06/06/2001 | CN1066718C Substituted aryloxy-alkyl diamines and its producing process and use |
| 06/05/2001 | US6242606 Reacting a a,a-dimethylphenylacetic acid amide with a w-halo compound produces w'-halo-a-keto-a,a-dimethylphenylacetic acid amide and reacting it with a piperidine compound; 2-(4-(4-chloro-butyryl)-phenyl)-2-methy-propionic acid |
| 06/05/2001 | US6242438 3-Azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 05/31/2001 | WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | WO2001038310A1 2-arylquinoline derivatives, preparation and therapeutic use thereof |
| 05/31/2001 | WO2001037826A1 Npyy5 antagonists |
| 05/31/2001 | CA2392149A1 2-arylquinoline derivatives, preparation and therapeutic use thereof |
| 05/31/2001 | CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/30/2001 | EP1102747A1 Crystalline forms of osanetant |
| 05/30/2001 | EP1102733A1 Method for reacting an organic compound with a hydroperoxide |
| 05/30/2001 | CN1297449A Novel 2-heterocyclically substd. dihydropyrimidines |
| 05/30/2001 | CN1066329C Preparation of drug composition |
| 05/29/2001 | US6239147 To treat cns, gastrointestinal and other disorders. substance p antagonists having improved activity and fewer side effects, treatment of emesis induced by antineoplastic agents, isochroman ring |
| 05/29/2001 | US6239135 Arylpiperazines having activity at the serotonin 1A receptor |
| 05/23/2001 | CN1296488A Bicycle hydroxamic acid derivatives |
| 05/23/2001 | CN1066142C 喹唑啉衍生物 Quinazoline derivatives |
| 05/22/2001 | US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis |
| 05/22/2001 | US6235778 Anticoagulants |
| 05/22/2001 | US6233841 Dehydration plant |
| 05/17/2001 | WO2001034593A1 Compound with growth hormone releasing properties |
| 05/17/2001 | WO2001007408A3 Novel method for preparing benzoperhydroisoindole compounds |
| 05/17/2001 | WO2000039098A9 Synthesis of histamine dihydrochloride |
| 05/16/2001 | EP1098897A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 05/16/2001 | CN1295562A Biocidal benzylbiphenyl derivatives |
| 05/15/2001 | US6231565 Robotic arm DLUs for performing surgical tasks |
| 05/15/2001 | CA2238978C Retroviral protease inhibiting compounds |
| 05/10/2001 | WO2001032654A2 Novel heterocyclic compounds and their use as medicines |
| 05/10/2001 | WO2001032651A1 Quinazoline derivatives as vegf inhibitors |
| 05/09/2001 | EP1097139A1 Quinoline derivatives |
| 05/08/2001 | US6229022 Reacting carbonyl compounds with hydrazine, its hydrate or salts in the presence of sulfuric acid and iodine or an iodine liberating compound |
| 05/08/2001 | US6229010 Recovering form i of 2-(r)-(1-(r)-(3,5-bis(trifluoromethyl) -phenyl)ethoxy)-3-(s)-(4-fluoro)phenyl-4-(3-(5-oxo-1h,4h-1,2,4 -triazolo)methylmorpholine from form ii equilibrated in ethanol, isopropanol, acetonitrile or isopropyl acetate |
| 05/08/2001 | CA2032330C Benzyl-substituted rhodanine derivatives for treating inflammatory bowel disease |
| 05/03/2001 | WO2001030760A1 Process for preparing 4-trifluoromethylsulphinylpyrazole derivative |
| 05/03/2001 | WO2001030759A2 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 05/03/2001 | WO2001030758A1 Drugs for the treatment of malignant tumours |
| 05/03/2001 | WO2001012607A3 Pharmaceutical compositions comprising 4-quinolones for treating cancers |
| 05/03/2001 | CA2389020A1 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 05/02/2001 | EP1095936A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 05/02/2001 | EP1094808A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone |
| 05/02/2001 | CN1065240C Taxanes having butenyl substituted side-chain and pharmaceutical compositions containing them |
| 05/01/2001 | US6225342 Use of calendula glycosides for the treatment of psoriasis |
| 04/26/2001 | WO2001029026A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 04/26/2001 | WO2001029008A1 Pyrazole derivatives which modulate human serotonin receptors |
| 04/26/2001 | WO2001028996A2 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases |
| 04/26/2001 | WO2001028992A2 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/26/2001 | CA2388859A1 Inhibitors of neuraminidases |
| 04/26/2001 | CA2387031A1 Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors |
| 04/26/2001 | CA2386910A1 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/25/2001 | EP0994872B1 4-phenylpiperidine compounds |
| 04/25/2001 | CN1292791A Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 04/25/2001 | CN1292779A Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| 04/25/2001 | CN1292683A Compositions containing organic compounds |
| 04/25/2001 | CN1292379A Preparation method of pyrazolzo [4,3-d] pyrimidine-7-ketone-3-pyridyl sulfonyl compound and its intermediate |
| 04/24/2001 | US6222038 As substance p antagonists; in therapy of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain |
| 04/19/2001 | WO2001027113A2 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES |
| 04/19/2001 | WO2001027112A1 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors |
| 04/19/2001 | CA2387353A1 Pharmaceutically active compounds |
| 04/18/2001 | EP1092720A2 Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof |
| 04/18/2001 | CN1291975A Process for preparing protected 4-aminomethyl-pyrrolidin-3-one |
| 04/18/2001 | CN1064680C Process for preparing magnesium omeprazole |
| 04/17/2001 | CA2220018C Crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 04/12/2001 | WO2001025242A1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 04/12/2001 | WO2001025200A1 Cyclic amine compounds as ccr5 antagonists |
| 04/12/2001 | CA2608807A1 Cyclic amine compounds as ccr5 antagonists |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1089984A1 Non-yellowing para-tertiary-alkyl phenyl substituted triazine and pyrimidine ultraviolet light absorbers |
| 04/11/2001 | EP1089735A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 04/11/2001 | CA2322995A1 Process for the preparation of pyrazolo ¬4,3-d|pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof |
| 04/10/2001 | US6215002 Cyclization, deblocking, deprotection, sulfonation, condensation, amidation; antiinflammatory agents; respiratory system disorders |
| 04/10/2001 | CA2086974C R(+)-terazosin |
| 04/04/2001 | EP1087976A1 Polymorphic clopidogrel hydrogenesulphate form |
| 04/04/2001 | EP1087934A1 Aminocyclohexyl ether compounds and uses thereof |
| 04/04/2001 | EP1087662A1 Composition for keeping away vermin |
| 04/04/2001 | CN1290258A Arylpiperazines having activity at the serotnin 1A receptor |
| 04/03/2001 | US6211381 Chemical intermediates |
| 04/03/2001 | US6211208 2-aminopyridines containing fused ring substituents |
| 04/03/2001 | CA2102772C Azetidinone compound and process for preparation thereof |
| 03/29/2001 | WO2001021596A1 Quinazoline derivatives and their use as pharmaceuticals |
| 03/29/2001 | WO2000075139A3 Benzothiazinone and benzoxazinone compounds |
| 03/29/2001 | CA2384291A1 Quinazoline derivatives and their use as pharmaceuticals |
| 03/28/2001 | EP1086093A1 Tetrahydroquinoline derivatives as glycine antagonists |
| 03/28/2001 | EP1085867A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty |
| 03/28/2001 | CN1289338A 2-(purin-9-yl)-tetahydrofuran-3,4-diol derivatives |
| 03/28/2001 | CN1063749C Azabicyclic esters of carbamino acids used in therapy |